ZA200107920B - Apomorphine and sildenafil composition. - Google Patents
Apomorphine and sildenafil composition.Info
- Publication number
- ZA200107920B ZA200107920B ZA200107920A ZA200107920A ZA200107920B ZA 200107920 B ZA200107920 B ZA 200107920B ZA 200107920 A ZA200107920 A ZA 200107920A ZA 200107920 A ZA200107920 A ZA 200107920A ZA 200107920 B ZA200107920 B ZA 200107920B
- Authority
- ZA
- South Africa
- Prior art keywords
- apomorphine
- sildenafil
- administered
- treatment
- sildenafil composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/270,035 US6087362A (en) | 1999-03-16 | 1999-03-16 | Apomorphine and sildenafil composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200107920B true ZA200107920B (en) | 2003-03-26 |
Family
ID=23029614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200107920A ZA200107920B (en) | 1999-03-16 | 2001-09-26 | Apomorphine and sildenafil composition. |
Country Status (21)
Country | Link |
---|---|
US (1) | US6087362A (fr) |
EP (1) | EP1173178B1 (fr) |
JP (1) | JP2002539163A (fr) |
CN (1) | CN1350454A (fr) |
AT (1) | ATE302003T1 (fr) |
AU (1) | AU3744500A (fr) |
BR (1) | BR0009016A (fr) |
CA (1) | CA2367605A1 (fr) |
CZ (1) | CZ20013344A3 (fr) |
DE (1) | DE60022021T2 (fr) |
DK (1) | DK1173178T3 (fr) |
ES (1) | ES2244418T3 (fr) |
HU (1) | HUP0200549A3 (fr) |
IL (1) | IL145487A0 (fr) |
MX (1) | MXPA01009332A (fr) |
NO (1) | NO324511B1 (fr) |
NZ (1) | NZ514464A (fr) |
PL (1) | PL350313A1 (fr) |
PT (1) | PT1173178E (fr) |
WO (1) | WO2000054774A1 (fr) |
ZA (1) | ZA200107920B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040063719A1 (en) * | 1998-08-26 | 2004-04-01 | Queen's University At Kingston | Combination therapy using antihypertensive agents and endothelin antagonists |
US6428769B1 (en) * | 1999-05-04 | 2002-08-06 | Aradigm Corporation | Acute testosterone administration |
US20020013327A1 (en) * | 2000-04-18 | 2002-01-31 | Lee Andrew G. | Compositions and methods for treating female sexual dysfunction |
MXPA03001858A (es) * | 2000-08-30 | 2004-05-21 | Unimed Pharmaceuticals Inc | Metodo para el tratamiento de la disfuncion erectil e incremento en el libido del hombre. |
US20030139384A1 (en) * | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US6821978B2 (en) * | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
NZ527113A (en) * | 2001-02-08 | 2005-04-29 | Pharmacia Corp | Rapid-onset medicament for the treatment of sexual dysfunction |
ES2180446B1 (es) * | 2001-07-02 | 2004-01-16 | Esteve Labor Dr | Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil. |
US20030044458A1 (en) * | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
AR036674A1 (es) * | 2001-08-28 | 2004-09-29 | Schering Corp | Inhibidores de fosfodiesterasa v de guanina de policiclicos, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos para tratar desordenes fisiologicos |
US20030114469A1 (en) * | 2001-09-27 | 2003-06-19 | Cohen David Saul | Combinations |
US20030216407A1 (en) * | 2002-01-31 | 2003-11-20 | Pfizer Inc. | Use of PDE5 inhibitors in the treatment of scarring |
US20060004190A1 (en) * | 2002-03-19 | 2006-01-05 | Michael Holick | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
US7037257B1 (en) * | 2002-08-22 | 2006-05-02 | Koenig J Frank | Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications |
TWI330529B (en) * | 2003-01-13 | 2010-09-21 | Horphag Res Luxembourg Holding Sa | A preparation for improving sperm quality or fertility,a kit comprising the same and uses thereof |
GB0304636D0 (en) * | 2003-02-28 | 2003-04-02 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition for nasal delivery |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7306812B2 (en) * | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
DE10325813B4 (de) * | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
KR101292492B1 (ko) * | 2004-05-11 | 2013-08-01 | 이모셔널 브레인 비.브이. | 약제학적 제형물 및 여성 성기능 부전의 치료에서 그것의용도 |
CN102406650A (zh) * | 2004-10-20 | 2012-04-11 | 恩多研究公司 | 单独的性甾体前体或与选择性雌激素受体调节剂联合用于防治绝经后女性的阴道疾病和病症 |
PT1937276E (pt) | 2005-10-12 | 2013-02-21 | Besins Healthcare Luxembourg | Gel de testosterona melhorado e método para a sua utilização |
CN101674728A (zh) * | 2007-02-12 | 2010-03-17 | Dmi生物科学公司 | 降低曲马多的副作用 |
KR20150089085A (ko) * | 2007-02-12 | 2015-08-04 | 브릭스 파마슈티컬스 인코퍼레이티드 | 조루 및 발기부전을 동시에 치료하는 방법 |
US20100035886A1 (en) | 2007-06-21 | 2010-02-11 | Veroscience, Llc | Parenteral formulations of dopamine agonists |
US8741918B2 (en) | 2007-06-21 | 2014-06-03 | Veroscience Llc | Parenteral formulations of dopamine agonists |
GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
DK2238168T3 (da) * | 2007-12-26 | 2014-08-25 | Biotest Ag | Midler, der er målrettet mod cd138 og anvendelser deraf |
RU2486203C2 (ru) * | 2007-12-26 | 2013-06-27 | Биотест Аг | Способы улучшения направленного воздействия на cd138-экспрессирующие опухолевые клетки и агенты для их осуществления |
EP2238169A1 (fr) * | 2007-12-26 | 2010-10-13 | Biotest AG | Procédé permettant de réduire les effets secondaires cytotoxiques et d'améliorer l'efficacité des immunoconjugués |
AU2008339911B2 (en) * | 2007-12-26 | 2014-02-27 | Biotest Ag | Immunoconjugates targeting CD138 and uses thereof |
US20090246298A1 (en) * | 2008-03-31 | 2009-10-01 | Ceola P. Steele | Viagra |
US20100184722A1 (en) * | 2008-12-19 | 2010-07-22 | Shimoda Biotech (Pty) Ltd | Inclusion complexes of alpha-cyclodextrin and sildenafil salt |
WO2010128087A2 (fr) * | 2009-05-06 | 2010-11-11 | Biotest Ag | Utilisations d'immunoconjugués ciblant l'antigène cd138 |
US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
AU2010259971C1 (en) | 2009-06-12 | 2017-02-16 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
WO2012000634A1 (fr) | 2010-06-29 | 2012-01-05 | Georg Bambach | Composition pharmaceutique pour le traitement de dysfonction érectile |
TWI462739B (zh) | 2010-11-02 | 2014-12-01 | Univ Kaohsiung Medical | Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途 |
CN103476372B (zh) | 2010-12-16 | 2016-04-27 | Cynapsus疗法有限公司 | 舌下薄膜 |
BR112014013694A2 (pt) | 2011-12-08 | 2017-06-13 | Biotest Ag | método para tratar uma doença, e, kit |
EP3285771A4 (fr) | 2015-04-21 | 2018-12-05 | Sunovion Pharmaceuticals Inc. | Méthodes de traitement de la maladie de parkinson par l'administration d'apomorphine à une muqueuse orale |
WO2017168174A1 (fr) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | Nouvelles formes pharmaceutiques du sildénafil |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256652A (en) * | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
DK0758895T3 (da) * | 1994-04-22 | 2000-06-13 | Pentech Pharmaceuticals Inc | Sublinguale dosisformer indeholdende apomorphin til anvendelse ved behandling af erektil dysfunktion |
GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
ES2270517T3 (es) * | 1997-05-19 | 2007-04-01 | Zonagen, Inc. | Terapia de combinacion para modular la respuesta sexual humana. |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
-
1999
- 1999-03-16 US US09/270,035 patent/US6087362A/en not_active Expired - Fee Related
-
2000
- 2000-03-14 JP JP2000604850A patent/JP2002539163A/ja active Pending
- 2000-03-14 MX MXPA01009332A patent/MXPA01009332A/es active IP Right Grant
- 2000-03-14 PT PT00916324T patent/PT1173178E/pt unknown
- 2000-03-14 ES ES00916324T patent/ES2244418T3/es not_active Expired - Lifetime
- 2000-03-14 HU HU0200549A patent/HUP0200549A3/hu unknown
- 2000-03-14 EP EP00916324A patent/EP1173178B1/fr not_active Expired - Lifetime
- 2000-03-14 CN CN00807580A patent/CN1350454A/zh active Pending
- 2000-03-14 DK DK00916324T patent/DK1173178T3/da active
- 2000-03-14 AU AU37445/00A patent/AU3744500A/en not_active Abandoned
- 2000-03-14 BR BR0009016-6A patent/BR0009016A/pt not_active Application Discontinuation
- 2000-03-14 CZ CZ20013344A patent/CZ20013344A3/cs unknown
- 2000-03-14 AT AT00916324T patent/ATE302003T1/de not_active IP Right Cessation
- 2000-03-14 PL PL00350313A patent/PL350313A1/xx not_active Application Discontinuation
- 2000-03-14 CA CA002367605A patent/CA2367605A1/fr not_active Abandoned
- 2000-03-14 WO PCT/US2000/006654 patent/WO2000054774A1/fr active IP Right Grant
- 2000-03-14 DE DE60022021T patent/DE60022021T2/de not_active Expired - Fee Related
- 2000-03-14 NZ NZ514464A patent/NZ514464A/xx unknown
- 2000-03-14 IL IL14548700A patent/IL145487A0/xx unknown
-
2001
- 2001-09-17 NO NO20014519A patent/NO324511B1/no unknown
- 2001-09-26 ZA ZA200107920A patent/ZA200107920B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1350454A (zh) | 2002-05-22 |
DE60022021T2 (de) | 2006-06-08 |
PL350313A1 (en) | 2002-12-02 |
US6087362A (en) | 2000-07-11 |
EP1173178A1 (fr) | 2002-01-23 |
MXPA01009332A (es) | 2002-06-21 |
NZ514464A (en) | 2004-01-30 |
IL145487A0 (en) | 2002-06-30 |
CZ20013344A3 (cs) | 2002-08-14 |
ATE302003T1 (de) | 2005-09-15 |
HUP0200549A3 (en) | 2004-07-28 |
DE60022021D1 (de) | 2005-09-22 |
CA2367605A1 (fr) | 2000-09-21 |
ES2244418T3 (es) | 2005-12-16 |
PT1173178E (pt) | 2005-11-30 |
HUP0200549A2 (hu) | 2002-07-29 |
JP2002539163A (ja) | 2002-11-19 |
DK1173178T3 (da) | 2005-11-07 |
AU3744500A (en) | 2000-10-04 |
BR0009016A (pt) | 2002-04-16 |
NO20014519L (no) | 2001-10-25 |
NO324511B1 (no) | 2007-11-05 |
NO20014519D0 (no) | 2001-09-17 |
EP1173178A4 (fr) | 2002-09-04 |
WO2000054774A1 (fr) | 2000-09-21 |
EP1173178B1 (fr) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL350313A1 (en) | Apomorphine and sildenafil composition | |
NZ540385A (en) | Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer | |
HK1177901A1 (en) | Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin 10--10- t | |
HRP20080598T3 (en) | Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer | |
CA2582452A1 (fr) | Doxorubicine liposomale pegylee en combinaison avec l'ecteinascidine 743 | |
NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
HK1077215A1 (en) | A pharmaceutical composition for treatment of acute myocardial infarction | |
CA2368614A1 (fr) | Traitement du cancer ameliore avec le temozolomide | |
JP2002540148A5 (fr) | ||
FI20011464A0 (fi) | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon | |
CA2516458A1 (fr) | Utilisation de composes de kahalalide pour la fabrication d'un medicament pour le traitement de psoriasis | |
MXPA02009603A (es) | Terapias de dosis divididas con actividad de deterioro vascular. | |
AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
PT1265629E (pt) | Utilizacao da hormona de crescimento em dose baixa | |
RU2002129097A (ru) | Комбинированные терапии с использованием активности, повреждающей сосуды | |
BRPI0503488A (pt) | agente de tratamento para sìndrome de intestino irritável com diarréia predominante |